Brind.

Entities / Company

Otsuka Pharmaceutical.

company

Seen in 10 reportsLast reported Aug 28

Reports this week: 0
Active events: 0
Connections: 40

What's happening

Reports per dayLast 90 days

90 days agoDrag either end to show only events that began in that periodToday

One to three months ago

Otsuka Pharmaceutical announces it is funding the LIFT-PD clinical study.

Some support1 report
Otsuka Pharmaceutical acquired the CAN10 program from Cantargia AB.

Some support2 reports

Gone quiet

No new reports in 90+ days

ICU Medical outlined its growth strategy and presented at a Wells Fargo conference, aiming to improve IV solutions via a joint venture.

Some support1 report

Around Otsuka Pharmaceutical this week

News at the entities that move Otsuka Pharmaceutical most

FDA Structural
Generic medicine services are seeking approval for launch from the FDA.

Moves Otsuka Pharmaceutical
Mon 17:49
Sto Mentioned together
Sto launched an Electronic Medical Record (EMR) system targeting the US physical therapy market.

Moves Otsuka Pharmaceutical
Mon 07:34

Connections

The 2 strongest of 40, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.

FDA Structural

Otsuka Pharmaceutical is seeking market approval from the FDA for its product centanafadine.

Some supportJul 14

Otsuka Pharmaceutical → FDA
FDA → Otsuka Pharmaceutical
Sto Mentioned together

Relationship between Otsuka Pharmaceutical and Sto is not supported by the provided evidence.

Some supportAug 19

Otsuka Pharmaceutical → Sto
Sto → Otsuka Pharmaceutical

History

Events by the month they began

August 2026

2 events

June 2026

1 event

Jun 7, 2026ICU Medical outlined its growth strategy and presented at a Wells Fargo conference, aiming to improve IV solutions via a joint venture.